Kumar, A. S. and Samuel, V. (2025) “Cost-Effectiveness of Co-Amoxiclav Versus Clindamycinin the Treatment of Uncomplicated Soft Tissue Infections in a Tertiary Care Hospital”, Journal of Health and Technology, 1(1), pp. 15–22. doi: 10.65129/clinical.v1i1.25.